Inhibin has greater specificity but calretinin greater sensitivity for ovarian sex cord-stromal tumours.
|
|||
Granulosa cell |
37/391 |
39/391 |
|
Sertoli-Leydig |
12/131 |
13/131 |
|
Sertoli cell tumour |
4/41 |
4/41 |
|
Thecoma |
8/91 |
9/91 |
|
Fibrothecoma |
11/141 |
14/141 |
|
Sclerosing stromal tumour |
2/21 |
2/21 |
|
Steroid cell |
3/31 |
3/31 |
|
other stromal tumours |
3/31 |
3/31 |
|
Sex cord-stromal neoplasms |
80/871 |
87/871 |
|
fibroma |
3/201 |
19/201 |
|
adenofibroma |
0/91 |
6/91 |
|
fibrosarcoma |
5/81 |
8/81 |
|
Fibrous neoplasms |
8/371 |
33/371 |
|
Serous carcinoma |
1/111 |
3/111 |
|
Atypical mucinous tumour |
0/191 |
6/191 |
|
Clear cell carcinoma |
0/71 |
1/71 |
|
Endometrioid carcinoma |
0/151 |
3/151 |
|
Brenner tumour |
0/131 |
1/131 |
|
Epithelial tumours |
1/651 |
||
Dysgerminoma |
0/71 |
0/71 |
|
Yolk sac tumour |
0/51 |
0/51 |
|
Choriocarcinoma |
0/11 |
0/11 |
|
Embryonal carcinoma |
0/11 |
0/11 |
|
Immature teratoma |
0/41 |
0/41 |
|
Mixed germ cell tumour |
0/41 |
0/41 |
|
Germ cell tumours |
0/221 |
0/221 |
|
Mixed Mullerian tumours |
0/21 |
0/21 |
|
Small cell carcinoma |
0/11 |
0/11 |
|
Clear cell sarcoma |
0/11 |
0/11 |
|
4: >75% of cells, 3: 50-75% of cells, 2: 25-50% of cells, 1: <25% of cells. Each asterisk denotes one case.
References